The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.
Expanding access to even the most basic form of cervical cancer screening and treatment could prevent thousands of deaths among women living with HIV in Kenya
In all regions, children show significant immune recovery after switching to second-line treatment, but still too many children switch late.
Lay health worker-led psychotherapy is an effective and cost-effective strategy to improve mental health outcomes among people living with HIV in low-resourced settings.
Two-thirds of South African mothers living with HIV are on effective treatment following the birth of their child, but only one-third of younger mothers are.
Evidence review finds approximately half of hospital patients with cryptococcal, tuberculosis or pneumococcal meningitis died within two weeks or during hospitalisation.
Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.
Study identifies new structural drivers of Uganda’s HIV epidemic alongside the persistence of known drivers such as stigma and gender-based violence.
Two-thirds of people with second-line treatment failure can reach viral suppression following adherence support in West Africa.
Switching from an antiretroviral treatment (ART) regimen containing tenofovir disoproxil fumarate (TDF) to a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide (ECETA) can improve bone density and kidney safety in those aged 60 and above, new study finds.
